These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6826774)

  • 1. Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives.
    Godsland IF; Seed M; Simpson R; Broom G; Wynn V
    J Clin Pathol; 1983 Feb; 36(2):184-91. PubMed ID: 6826774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal values for peripheral blood white cell counts in women of four different ethnic origins.
    Bain B; Seed M; Godsland I
    J Clin Pathol; 1984 Feb; 37(2):188-93. PubMed ID: 6693578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
    Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ
    Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994.
    Dong W; Colhoun HM; Poulter NR
    J Hypertens; 1997 Oct; 15(10):1063-8. PubMed ID: 9350579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron stores in users of oral contraceptive agents.
    Frassinelli-Gunderson EP; Margen S; Brown JR
    Am J Clin Nutr; 1985 Apr; 41(4):703-12. PubMed ID: 3984924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
    Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
    Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use and blood pressure in a German metropolitan population.
    Cairns V; Keil U; Doering A; Koenig W; Stieber J; Kleinbaum DG
    Int J Epidemiol; 1985 Sep; 14(3):389-95. PubMed ID: 3877006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
    Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
    Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives, anti-thrombin III and fibrinolytic activity in Africans.
    Greig HB
    Acta Haematol; 1977; 58(3):138-44. PubMed ID: 409028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic abnormalities in adolescents who take oral contraceptive pills.
    Grace E; Emans SJ; Drum DE
    J Pediatr; 1982 Nov; 101(5):771-4. PubMed ID: 7131157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of the "Beaumont" protein in serum of oral contraceptive users.
    Collins DC; Bain RP; Coan P; Macpherson RF; Blumenstein B; Hall WD
    Fertil Steril; 1983 Oct; 40(4):490-6. PubMed ID: 6617910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of women using different methods of contraception--some preliminary findings from a prospective study.
    Vessey MP; Doll R; Peto R; Redman G
    Int J Epidemiol; 1972; 1(2):119-23. PubMed ID: 4669186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
    Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
    Larsson G; Milsom I; Lindstedt G; Rybo G
    Contraception; 1992 Oct; 46(4):327-34. PubMed ID: 1486771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.